New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
UCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases
2014-08-19
(Press-News.org) In many parts of the world, leprosy and tuberculosis live side-by-side. Worldwide there are approximately 233,000 new cases of leprosy per year, with nearly all of them occurring where tuberculosis is endemic.
The currently available century-old vaccine Bacille Calmette-Guerin, or BCG, provides only partial protection against both tuberculosis and leprosy, so a more potent vaccine is needed to combat both diseases. UCLA-led research may have found a stronger weapon against both diseases.
In a study published in the September issue of the peer-reviewed journal Infection and Immunity, the researchers found that rBCG30, a recombinant variant of BCG that overexpresses a highly abundant 30 kDa protein of the tuberculosis bacterium known as Antigen 85B, is superior to BCG in protecting against tuberculosis in animal models, and also cross protects against leprosy. In addition, they found that boosting rBCG30 with the Antigen 85B protein, a protein also expressed by the leprosy bacillus, provides considerably stronger protection against leprosy.
"This is the first study demonstrating that an improved vaccine against tuberculosis also offers cross-protection against Mycobacterium leprae, the causative agent of leprosy," said Dr. Marcus A. Horwitz, professor of medicine and microbiology, immunology and molecular genetics, and the study's senior author. "That means that this vaccine has promise for better protecting against both major diseases at the same time.
"It is also the first study demonstrating that boosting a recombinant BCG vaccine further improves cross-protection against leprosy," he added.
In one experiment, mice were immunized with either rBCG30 or the old BCG vaccine, or they were given a salt solution. Ten weeks later, the mice were injected with live leprosy bacteria into their footpads and seven months after that, the number of leprosy bacteria in their footpads was measured. The researchers found that the mice given BCG or rBCG30 had much fewer leprosy bacteria in their footpads than the mice given the salt solution. Additionally, mice immunized with rBCG30 had significantly fewer leprosy bacteria than those vaccinated with BCG.
In a second experiment, the mice were first immunized with BCG or rBCG30, and then immunized with a booster vaccine (r30) consisting of the TB bacterium's 30-kDa Antigen 85B protein in adjuvant — that is, in a chemical formulation that enhances the immune response. The group of mice immunized with rBCG30 and boosted with r30 had no detectable leprosy bacteria in their footpads, in contrast to groups of mice immunized with all other vaccines tested, including BCG and rBCG30 alone and BCG boosted with r30.
In other experiments, the immune responses of the mice were measured after vaccination. Mice immunized with rBCG30 and boosted with r30 had markedly enhanced immune responses to the leprosy bacterium's version of the Antigen 85B protein, which is very similar to the one expressed by the tuberculosis bacillus, compared with mice immunized with the other vaccines and vaccine combinations.
A Phase 1 human trial for rBCG30 has proven that it is safe and significantly more effective than BCG, and it is the only candidate replacement vaccine for BCG tested thus far to satisfy both of these key clinical criteria. Horwitz noted that this most recent study, however, was conducted in an animal model of leprosy, so further study is needed to gauge the effectiveness of the rBCG30 vaccine in protecting against leprosy in humans.
The next step in the research will be to test the rBCG30 vaccine for efficacy in humans against TB. If it's effective against TB, then the next step would be to test its effectiveness in humans against leprosy.
INFORMATION:
The study's co-authors are Thomas Gillis of Louisiana State University and Michael Tullius of UCLA.
Grants from the National Institutes of Health (AI031338) and the National Hansen's Disease Programs funded this study. In addition, grants from UCLA's Jonsson Comprehensive Cancer Center (P30 CA016042) and the Center for AIDS Research (5P30 AI028697) supported flow cytometry studies used to measure immune responses, and the American Leprosy Missions supported the nude mouse colony used for the propagation of M. leprae.
ELSE PRESS RELEASES FROM THIS DATE:
Seafood substitutions can expose consumers to unexpectedly high mercury
2014-08-19
New measurements from fish purchased at retail seafood counters in 10 different states show the extent to which mislabeling can expose consumers to unexpectedly high levels of mercury, a harmful pollutant.
Fishery stock "substitutions"—which falsely present a fish of the same species, but from a different geographic origin—are the most dangerous mislabeling offense, according to new research by University of Hawai'i at Mānoa scientists.
"Accurate labeling of seafood is essential to allow consumers to choose sustainable fisheries," said UH Mānoa biologist Peter ...
Engineering new bone growth
2014-08-19
CAMBRIDGE, MA -- MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, this coated scaffold induces the body to rapidly form new bone that looks and behaves just like the original tissue.
This type of coated scaffold could offer a dramatic improvement over the current standard for treating bone injuries, which involves transplanting bone from another part of the patient's body — a painful process that does not always supply enough bone. ...
Antibacterial soap exposes health workers to high triclosan levels
2014-08-19
Handwashing with antibacterial soap exposes hospital workers to significant and potentially unsafe levels of triclosan, a widely-used chemical currently under review by the U.S. Food and Drug Administration, according to a study led by researchers from UC San Francisco.
Triclosan, a synthetic antibacterial agent, is found in thousands of consumer products, including soaps, cosmetics, acne creams and some brands of toothpaste. The FDA is reviewing its safety based on a growing body of research indicating that it can interfere with the action of hormones, potentially causing ...
Solar energy that doesn't block the view
2014-08-19
A team of researchers at Michigan State University has developed a new type of solar concentrator that when placed over a window creates solar energy while allowing people to actually see through the window.
It is called a transparent luminescent solar concentrator and can be used on buildings, cell phones and any other device that has a flat, clear surface.
And, according to Richard Lunt of MSU's College of Engineering, the key word is "transparent."
Research in the production of energy from solar cells placed around luminescent plastic-like materials is not new. ...
NMR using Earth's magnetic field
2014-08-19
Earth's magnetic field, a familiar directional indicator over long distances, is routinely probed in applications ranging from geology to archaeology. Now it has provided the basis for a technique which might, one day, be used to characterize the chemical composition of fluid mixtures in their native environments.
Researchers from the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) conducted a proof-of-concept NMR experiment in which a mixture of hydrocarbons and water was analyzed using a high-sensitivity magnetometer and a magnetic ...
Biomarker in an aggressive breast cancer is identified
2014-08-19
Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer.
Using breast cancer patient data taken from The Cancer Genome Atlas, molecular biologists Curt M. Horvath and Robert W. Tell used powerful computational and bioinformatics techniques to detect patterns of gene expression in two cancer subtypes. They ...
Nurse staffing and mortality in stroke centers
2014-08-19
Hospital staffing levels have been associated with patient outcomes, but staffing on weekends has not been well studied, despite a recent UK mandate to make physician specialist care 7 days a week a policy and service improvement priority for the National Health Service. To help address the paucity of research on the association of weekend staffing with patient outcomes, Dr. Benjamin Bray of King's College London and Royal College of Physicians, United Kingdom, and colleagues conducted a prospective cohort study of weekend staffing with stroke specialist physicians for ...
Blood glucose levels measured in hospitalized patients can predict risk of type 2 diabetes
2014-08-19
Blood glucose levels measured in hospitalized adults during acute illness can be used to predict risk of developing type 2 diabetes over the following 3 years, according to a study published by David McAllister and colleagues from the University of Edinburgh, UK in this week's PLOS Medicine.
The researchers obtained measurements of blood glucose levels on admission for 86,634 patients aged 40 years or older who were admitted to a hospital for an acute illness between 2004 and 2008 in Scotland and identified those patients who developed type 2 diabetes up to December 2011 ...
Electrical engineers take major step toward photonic circuits
2014-08-19
Edmonton—The invention of fibre optics revolutionized the way we share information, allowing us to transmit data at volumes and speeds we'd only previously dreamed of.
Now, electrical engineering researchers at the University of Alberta in Edmonton, Alberta, Canada are breaking another barrier, designing nano-optical cables small enough to replace the copper wiring on computer chips.
This could result in radical increases in computing speeds and reduced energy use by electronic devices.
"We're already transmitting data from continent to continent using fibre optics, ...
New study first to examine quality of cardiac rehabilitation programs in Canada
2014-08-19
The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Centre, York University and UHN.
"We are the first to comprehensively assess cardiac rehabilitation quality --- what we are doing well and where we should do better --- to this degree across the country," says Dr. Sherry Grace, study author, Director of Research, GoodLife Fitness Cardiovascular Rehabilitation Unit, University ...
LAST 30 PRESS RELEASES:
New strategies to enhance chiral optical signals unveiled
Cambridge research uncovers powerful virtual reality treatment for speech anxiety
2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research
International survey finds that support for climate interventions is tied to being hopeful and worried about climate change
Cambridge scientist launches free VR platform that eliminates the fear of public speaking
Open-Source AI matches top proprietary model in solving tough medical cases
Good fences make good neighbors (with carnivores)
NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer
Introducing our new cohort of AGA Future Leaders
Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help
Engineering excellence: Engineers with ONR ties elected to renowned scientific academy
New CRISPR-based diagnostic test detects pathogens in blood without amplification
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Growing solar: Optimizing agrivoltaic systems for crops and clean energy
Scientists discover how to reactivate cancer’s molecular “kill switch”
YouTube influencers: gaming’s best friend or worst enemy?
uOttawa scientists use light to unlock secret of atoms
NJIT mathematician to help map Earth's last frontier with Navy grant
NASA atmospheric wave-studying mission releases data from first 3,000 orbits
‘Microlightning’ in water droplets may have sparked life on Earth
Smoke from wildland-urban interface fires more deadly than remote wildfires
What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood
Protein accidentally lassos itself, helping explain unusual refolding behavior
With bird flu in raw milk, many in U.S. still do not know risks of consuming it
University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease
UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS
Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it
A closer look at biomolecular ‘silly putty’
Oxytocin system of breastfeeding affected in mothers with postnatal depression
Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles
[Press-News.org] New vaccine shows promise as stronger weapon against both tuberculosis and leprosyUCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases